Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

被引：0
|
作者：
Ciro Franzese
Veronica Vernier
Davide Franceschini
Tiziana Comito
Pierina Navarria
Elena Clerici
Maria Ausilia Teriaca
Maria Massaro
Luciana Di Cristina
Beatrice Marini
Carmela Galdieri
Pietro Mancosu
Stefano Tomatis
Marta Scorsetti
机构：
[1] Humanitas University,Department of Biomedical Sciences
[2] IRCCS Humanitas Research Hospital,Department of Radiotherapy and Radiosurgery
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Oligometastatic; SBRT; SABR; Stereotactic radiotherapy; Oligometastases; Multiple; Radiosurgery; Stereotactic ablative radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10495 / 10503
页数：8
相关论文
共 50 条
  • [31] Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for up to 5 Oligometastases: Preliminary Results of the SABR-5 Trial
    Olson, R. A.
    Jiang, W.
    Liu, M. C.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Hsu, F.
    Miller, S.
    Atrchian, S.
    Chan, E. K.
    Ho, C.
    Mohamed, I. G.
    Lin, A.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Huang, V.
    Mestrovic, T.
    Hyde, D.
    Lund, C. R.
    Pai, H. H.
    Valev, B.
    Lefresne, S.
    Tyldesley, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S4 - S4
  • [32] Prognostic role of texture analysis in lung cancer treated with stereotactic ablative radiotherapy (SABR)
    Nardone, V.
    Tini, P.
    Mazzoni, L. N.
    La Penna, A.
    Biondi, M.
    Sebaste, L.
    Carfagno, T.
    Vanzi, E.
    De Otto, G.
    Battaglia, G.
    Pastina, P.
    Carbone, S. F.
    Buonamici, F. Banci
    Pirtoli, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Outcomes in locally recurrent rectal cancer treated with reirradiation stereotactic ablative radiotherapy (SABR)
    Muirhead, R.
    Aitken, K.
    Holmes, J.
    Harrison, M.
    Harji, D.
    O'Cathail, S.
    Taylor, C.
    Wing, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1041 - S1042
  • [34] Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No
    Macbeth, F.
    Hughes-Davies, L.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 749 - 750
  • [35] Clinical Characteristics Matrix of Lung Tumor Under Stereotactic Ablative Body Radiotherapy (SABR)
    Li, K.
    Jung, E.
    Wu, B.
    Mousli, A.
    Aoki, S.
    Newton, J.
    Able, A.
    Cornell, D.
    Lee, N.
    Lo, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2333 - S2333
  • [36] Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis
    Satyanarayan, Arthi
    Mooney, Ryan
    Bhanvadia, Raj R.
    Iyengar, Puneeth
    Margulis, Vitaly
    Desai, Neil B.
    Bagrodia, Aditya
    CLINICAL GENITOURINARY CANCER, 2019, 17 (04) : E768 - E771
  • [37] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [38] Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors
    Moding, E. J.
    Maxim, P. G.
    Diehn, M.
    Loo, B. W., Jr.
    Gensheimer, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E482 - E482
  • [39] Splenic Irradiation and Late Volume Changes Following Stereotactic Ablative Radiotherapy (SABR) for Adrenal Tumors
    Giraud, N.
    Schneiders, F. L.
    de Koste, J. R. van Sornsen
    Palacios, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E385 - E386
  • [40] EARLY ACUTE TOXICITIES IN STEREOTACTIC ABLATIVE RADIOTHERAPY FOR PROSTATE CANCER PATIENTS WITH SYNCHRONOUS OLIGOMETASTASES
    Fazio, Ivan
    Tulone, Gabriele
    Baiamonte, Davide
    Borsellino, Nicolo
    Federico, Manuela
    Bruno, Tiziana
    Serretta, Vincenzo
    ANTICANCER RESEARCH, 2020, 40 (08) : 4627 - 4628
12345